Monoclonal antibodies specific for oncofetal antigen – immature laminin receptor protein: Effects on tumor growth and spread in two murine models

References

• Malinoff HL, Wicha MS. Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol 1983 96:1475-9; PMID:6302102; http://dx.doi.org/10.1083/jcb.96.5.1475
   PubMed Web of Science ®Google Scholar
• Rao NC, Barsky SH, Terranova VP, Liotta LA. Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 1983 111:804-8; PMID:6301485; http://dx.doi.org/10.1016/0006-291X(83)91370-0
   PubMed Web of Science ®Google Scholar
• Lesot H, Kuhl U, Mark KV. Isolation of a laminin-binding protein from muscle cell membranes. EMBO J 1983 2:861-65; PMID:16453457
   PubMed Web of Science ®Google Scholar
• Terranova VP, Rao CN, Kalebic T, Margulies IM, Liotta LA. Laminin receptor on human breast carcinoma cells. Proc Nat Acad Sci U S A 1983 80:444-8.
   Google Scholar
• Menard S, Tagliabue E, Colnaghi MI. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treatment 1998 52:137-45; PMID:10066078; http://dx.doi.org/10.1023/A:1006171403765
   PubMed Web of Science ®Google Scholar
• Rao CN, Castronovo V, Schmitt MD, Wewer UM, Claysmith AP, Liotta LA, Sobel ME. Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry 1989 28:7476-86; PMID:2531008; http://dx.doi.org/10.1021/bi00444a047
   PubMed Web of Science ®Google Scholar
• Castronovo V, Taraboletti G, Sobel ME. Functional domains of the 67-kDa laminin receptor precurson. J Biol Chem 1991 266:20440-6; PMID:1834645
   PubMed Web of Science ®Google Scholar
• Landowski TH, Dratz EA, Starkey JR. Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein. Biochemistry 1995 34:11276-87; PMID:7669786; http://dx.doi.org/10.1021/bi00035a037
   PubMed Web of Science ®Google Scholar
• Buto S, Tagliabue E, Ardini E, Magnifico A, Ghirelli C, van den Brule F, Castronovo V, Colnaghi MI, Sobel ME, Ménard S. Formation of the 67-kDa laminin receptor by acylation of the precursor. J. Cell Biochem 1998 69:244-51; PMID:9581863; http://dx.doi.org/10.1002/(SICI)1097-4644(19980601)69:3%3c244::AID-JCB2%3e3.0.CO;2-R
   PubMed Web of Science ®Google Scholar
• Coggin JH Jr, Rohrer SD, Leinbach ED, Hester RB, Liu PI, Heath LS. Radiation-induced lymphoblastic lymphomas/leukemias and sarcomas of mice express conserved immunogenic 44-kilodalton oncofetal antigen. Amer. Pathol 1988 130:136-46; PMID:3337209
   PubMed Web of Science ®Google Scholar
• Payne WJ, Jr. Coggin JH, Jr. Mouse monoclonal antibody to embryonic antigen: Development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization. JNCI 1985 75:527-44; PMID:2411994
   PubMed Web of Science ®Google Scholar
• Barsoum AL, Coggin JH, Jr. Isolation and partial characterization of a soluble oncofetal antigen from murine and human amniotic fluids. Int J Cancer 1991 48:248-52; PMID:1850386; http://dx.doi.org/10.1002/ijc.2910480216
   PubMed Web of Science ®Google Scholar
• Barsoum AL, Coggin JH, Jr. Immunogenicity of a soluble, partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice. J Biol Response Mod 1989 8:579-92; PMID:2600602
   PubMedGoogle Scholar
• Gussack GS, Rohrer SD, Hester RB, Barsoum A, Coggin JH, Jr. Human squamous cell carcinoma lines express oncogetal 44-kd polypeptide defined by monoclonal antibody to mouse fetus. Cancer 1988 62:283-90; PMID:3289728; http://dx.doi.org/10.1002/1097-0142(19880715)62:2%3c283::AID-CNCR2820620210%3e3.0.CO;2-O
   PubMed Web of Science ®Google Scholar
• Gussack GS, Harris W, Rohrer S, Hester R, Liu P, Coggin JH, Jr. Comparison of cellular and antigenic tumor characteristics between primary head and neck carcinomas and their derived tumor cell lines. In: Head and Neck Oncology Research, Taylor & Francis, Amsterdam, p. 121-31 (1988).
   Google Scholar
• Coggin JH, Jr, Barsoum AL, Rohrer JW. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers. Anticancer Res 1999 19:5532-42
   Google Scholar
• Rohrer JW, Barsoum AL, Coggin JH, Jr. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones. J Immunol 2006 176:2844-56; PMID:16493041; http://dx.doi.org/10.4049/jimmunol.176.5.2844
   PubMed Web of Science ®Google Scholar
• Siegel S, Wagner A, Kabelitz D, Marget M, Coggin JH, Jr., Barsoum A, Rohrer J, Schmitz N, Zeis M. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies. Blood 2003 102:4416-23; PMID:12869512; http://dx.doi.org/10.1182/blood-2003-01-0198
   PubMed Web of Science ®Google Scholar
• Friedrichs B, Siegel S, Kloess M, Barsoum A, Coggin J, Jr., Rohrer J, Jakob I, Tiemann M, Heidorn K, Schulte C, et al. Humoral immune responses against immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia. J Immunol 2008 180:6374-84; PMID:18424761; http://dx.doi.org/10.4049/jimmunol.180.9.6374
   PubMed Web of Science ®Google Scholar
• Siegel S, Friedrichs B, Budde AK, Barsoum A, Coggin J Jr, Tiemann M, Kabelitz D, Zeis M.. In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells - clinical implications. Leukemia 2008 22:2115-8
   PubMed Web of Science ®Google Scholar
• Friedrichs B, Siegel S, Reimer R, Barsoum A, Coggin J, Jr., Kabeitz D, Heidorn K, Schulte C, Schmitz N, Zeis M. High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia. Leukemia Res 2011 35:721-9; PMID:21055809; http://dx.doi.org/10.1016/j.leukres.2010.10.002
   PubMed Web of Science ®Google Scholar
• Kanti RR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. New Eng J Med 2000 343:1750-7; PMID:11114313
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepdretre S, Pdersen LM, Gadeberg O, Fredriksen H, van Oers MH, Wooldridge J, Kloczko J, Holowiecki J, Hellmann A, et al. Safety and efficacy of ofatumumat, a fully human monoclonal anti-CD20 antibody in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1–2 study. Blood 2008 111:1094-100; PMID:18003886; http://dx.doi.org/10.1182/blood-2007-09-111781
   PubMed Web of Science ®Google Scholar
• Hehlmann R, Berger U, Pfirmann M, Heimpel H, Hochhaus A, Hasford J. Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Blood 2007 109:4686-92; PMID:17317858; http://dx.doi.org/10.1182/blood-2006-11-055186
   PubMed Web of Science ®Google Scholar
• Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbauum F. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European Leukemia Network. Blood 2006 108:1809-20; PMID:16709930; http://dx.doi.org/10.1182/blood-2006-02-005686
   PubMed Web of Science ®Google Scholar
• Hehlmann R, Saussele. Treatment of chronic myeloid leukemia in blast crisis. Haematologica 2008 93:1765-9; PMID:19050065; http://dx.doi.org/10.3324/haematol.2008.001214
   PubMed Web of Science ®Google Scholar
• Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. Activity of a specific inhibitor of the BCL-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with Philadelphia chromosome. New Eng J Med 2001 344:1038-42; PMID:11287973; http://dx.doi.org/10.1056/NEJM200104053441402
   PubMed Web of Science ®Google Scholar
• Hallek M, Fischer K, Fingerle-Rowson G. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia: a randomised, open-label, phase 3 trial. Lancet 2010 376:1164-74; PMID:20888994; http://dx.doi.org/10.1016/S0140-6736(10)61381-5
   PubMed Web of Science ®Google Scholar
• Omar A, Reusch U, Knackmuss S, little M, Weiss SFT. Anti-LRP/LR - specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells. J Molec Biol 2012 419:102-9; PMID:22391421; http://dx.doi.org/10.1016/j.jmb.2012.02.035
   PubMed Web of Science ®Google Scholar
• Zuber C, Knackmuss S, Zemora G, Reusch U, Vlasova E, Diehl D, Mick V, Hoffmann K, Nikles D, Frohlich T, Arnold GJ, Brenig B, Wolf E, Lahm H, et al. Invasion of tumorigenic HT1080 cells is impeded by blocking or down-regulating the 37-kDa/67-kDa laminin receptor. J Molec Biol 2008 378:530-9; PMID:18387633; http://dx.doi.org/10.1016/j.jmb.2008.02.004
   PubMed Web of Science ®Google Scholar
• Khalfaoul T, Grouix J-F, Sabra G, GuezGuez A, Basora N, Vermette P, Beaulieu J-F. laminin receptor 37/67LR regulates adhesion and proliferation of normal human intestinal cells. Plos One 2013 8:e74337; PMID:23991217; http://dx.doi.org/10.1371/journal.pone.0074337
   PubMedGoogle Scholar
• Ferrarini M, Heltai S, Pupa SM, Menard S, Zocchi MR. Killing of laminin receptor-positive human lung cancers by tumor-infiltrating lymphocytes bearing gd T-cell receptors. J Nat Cancer Inst 1996 88: 436-41; PMID:8618235; http://dx.doi.org/10.1093/jnci/88.7.436
   PubMed Web of Science ®Google Scholar
• Barsoum A, Liu B, Rohrer JW, Coggin JH, Jr., Tucker JA, Pannell LK, Schwarzenberger PO. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein. Biomaterials 200930:3091-9; PMID:19268360; http://dx.doi.org/10.1016/j.biomaterials.2009.02.022
   PubMed Web of Science ®Google Scholar
• Beatty JD, Beatty BG, Vlahos WG. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987: 100:173-9; PMID:2439600; http://dx.doi.org/10.1016/0022-1759(87)90187-6
   PubMed Web of Science ®Google Scholar
• Myszka DG, Rich RL. Advances in surface plasmon resonance biosensor analysis. Curr Opin Biotechnol 2000 11:54-61; PMID:10679342; http://dx.doi.org/10.1016/S0958-1669(99)00054-3
   PubMed Web of Science ®Google Scholar
• Ball JM, Henry NL, Montelaro RC, Newman MJ. A versatile synthetic peptide-based ELISA for identifying antibody epitopes. J. Immunological Methods 1994 171, 37-44; PMID:7513733; http://dx.doi.org/10.1016/0022-1759(94)90226-7
   PubMed Web of Science ®Google Scholar
• Varani J, Perone P, Griffiths CE, Inman DR, Fligiel SE, Voorhees JJ. All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest 1994 94:1747-56; PMID:7962521; http://dx.doi.org/10.1172/JCI117522
   PubMed Web of Science ®Google Scholar